Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567606 · ClinicalTrials.gov registry record · NA
Prevention of Osteoporosis in Breast Cancer Survivors
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 249
- Enrollment target
NCT00567606: Completed NA study, sponsored by University of Nebraska.
NCT00567606 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567606, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 249 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether strength/weight training exercises enhance the effectiveness of calcium, vitamin D, and risedronate for the prevention and treatment of osteoporosis in postmenopausal breast cancer survivors.
Primary Outcome
Bone Mineral Density (gm/cm2) will be measured by Dual-Energy X-ray Absorptiometry (DEXA) of the hip, spine and forearm
Interventions
- OTHER Strength/Weight Training & Drug/Supplement
- COMBINATION_PRODUCT Drug/Supplement only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2002-04-01 |
| Est. Completion | 2007-12-01 |
| Phase | NA |
What the finished NCT00567606 record still lists
NCT00567606 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Strength/Weight Training & Drug/Supplement is the first listed.
NCT00567606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00567606 about?
NCT00567606 is a clinical study titled "Prevention of Osteoporosis in Breast Cancer Survivors". The purpose of this study is to test whether strength/weight training exercises enhance the effectiveness of calcium, vitamin D, and risedronate for the prevention and treatment of osteoporosis in postmenopausal breast cancer survivors.
What is the current status of trial NCT00567606?
This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2002-04-01. Estimated completion is 2007-12-01.
What interventions are being tested in trial NCT00567606?
The interventions under investigation include: Strength/Weight Training & Drug/Supplement (OTHER), Drug/Supplement only (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00567606?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00567606's enrollment target sits among peer trials
249 434th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI